glp-1 agonist gastroparesis Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine Researchers find GLP-1 medications safe

38 Grauslund et al identified all patients with diabetes in Denmarks national health registry and found that semaglutide was an independent predictor of incident NAION (HR = 2.19)

Prepare for trial: If a settlement cannot be reached, the matter will be set for trial

doi: 10.1136/tsaco-2018-000219

doi: 10.1128/mcb.16.1.19

Furthermore, many drugs used to treat diabetes, such as SUs, TZDs, and insulin, are associated with weight gain

Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial